Table of Contents
Advertisement
FDA shares regulatory responsibilities for wireless phones with the
Federal Communications Commission (FCC). All phones that are sold
in the United States must comply with FCC safety guidelines that limit
RF exposure. FCC relies on FDA and other health agencies for safety
questions about wireless phones.
FCC also regulates the base stations that the wireless phone
networks rely upon. While these base stations operate at higher
power than do the wireless phones themselves, the RF exposures
that people get from these base stations are typically thousands of
times lower than those they can get from wireless phones. Base
stations are thus not the primary subject of the safety questions
discussed in this document.
4. What is FDA doing to find out more about the possible health
effects of wireless phone RF?
FDA is working with the U.S. National Toxicology Program and with
groups of investigators around the world to ensure that high priority
animal studies are conducted to address important questions about
the effects of exposure to radio frequency energy (RF).
FDA has been a leading participant in the World Health Organization
International Electromagnetic Fields (EMF) Project since its inception
in 1996. An influential result of this work has been the development
of a detailed agenda of research needs that has driven the
establishment of new research programs around the world. The
Project has also helped develop a series of public information
documents on EMF issues.
FDA and the Cellular Telecommunications & Internet Association
(CTIA) have a formal Cooperative Research and Development
Agreement (CRADA) to do research on wireless phone safety. FDA
provides the scientific oversight, obtaining input from experts in
government, industry, and academic organizations. CTIA-funded
research is conducted through contracts to independent
investigators. The initial research will include both laboratory studies
Health and Safety Information
166
Advertisement
Table of Contents
